4//SEC Filing
Kelly Paul Edward 4
Accession 0001213900-22-000761
CIK 0001553643other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:01 PM ET
Size
7.0 KB
Accession
0001213900-22-000761
Insider Transaction Report
Form 4
Kelly Paul Edward
DirectorChief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2022-01-03$3.24/sh−20,000$64,800→ 187,295 total - Exercise/Conversion
Options to purchase common stock
2022-01-03−20,000→ 30,500 totalExercise: $3.24From: 2017-10-20Exp: 2027-10-20→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period.
- [F2]Not applicable.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001658544
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:01 PM ET
- Size
- 7.0 KB